Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models

키워드

참고문헌 (36)

1. Arthur MJ, "Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C", Gastroenterology, 122, pp.1525~1528 (2002)
2. Kweon YO, "Decreasing fibrogenesis : an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B", J Hepatol, 35, pp.749~755 (2001)
3. 정영걸, "Reversal of liver cirrhosis: current evidence and expectations", The Korean Journal of Internal Medicine, 32(2), pp.213~228 (2017), 대한내과학회[DOI]
4. Friedman SL, "Mechanisms of hepatic fibrogenesis", Gastroenterology, 134, pp.1655~1669 (2008)
5. Saile B, "Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells", Hepatology, 30, pp.196~202 (1999)
6. Costa AM, "Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress", Virchows Arch, 442, pp.372~380 (2003)
7. Fan X, "Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1", PLoS One, 8, pp.e82190~ (2013)
8. Lan T, "Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation", PLoS One, 10, pp.e0129743~ (2015)
9. Barry-Hamilton V, "Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment", Nat Med, 16, pp.1009~1017 (2010)
10. Lee SJ, "Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line", J Gastroenterol Hepatol, 29, pp.1299~1307 (2014)
11. Nogaki F, "Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells", Kidney Int Suppl, 71, pp.S198~S201 (1999)
12. Park HJ, "3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase", Proc Natl Acad Sci U S A, 96, pp.11525~11530 (1999)
13. Yoshimura A, "Effect of simvastatin on proliferative nephritis and cell-cycle protein expression", Kidney Int Suppl, 71, pp.S84~S87 (1999)
14. Hawkey CJ, "COX-2 inhibitors", Lancet, 353, pp.307~314 (1999)
15. Hui AY, "Effect of celecoxib on experimental liver fibrosis in rat", Liver Int, 26, pp.125~136 (2006)
16. Friedman SL, "Liver fibrosis : from bench to bedside", J Hepatol, 38(Suppl 1), pp.S38~S53 (2003)
17. Schellenberg B, "Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming", Mol Cell, 49, pp.959~971 (2013)
18. Santibanez JF, "Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras", MAPK signaling pathway in transformed keratinocytes, 2002, pp.296, 267~273
19. Hemmann S, "Expression of MMPs and TIMPs in liver fibrosis : a systematic review with special emphasis on anti-fibrotic strategies", J Hepatol, 46, pp.955~975 (2007)
20. Garcia-Ruiz I, "Sp1and Sp3 transcription factors mediate leptin-induced collagen α1(I)gene expression in primary culture of male rat hepatic stellate cells", Endocrinology, 153, pp.5845~5856 (2012)
21. Aprigliano I, "Atorvastatin induces apoptosis by a caspase-9-dependent pathway : an in vitro study on activated rat hepatic stellate cells", Liver Int, 28, pp.546~557 (2008)
22. Paik YH, "Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats", Gut, 58, pp.1517~1527 (2009)
23. Ruffels J, "Activation of ERK1", 2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells : role of ERK1, Eur J Pharmacol, pp.2004, 483[DOI]
24. Green DR, "Mitochondria and apoptosis", Science, 281, pp.1309~1312 (1998)
25. Eberlein M, "Rho-dependent inhibition of the induction of connective tissue growth factor(CTGF)by HMG CoA reductase inhibitors(statins)", Br J Pharmacol, 133, pp.1172~1180 (2001)
26. Patel R, "Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy", Circulation, 104, pp.317~324 (2001)
27. Watts KL, "Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts", Am J Respir Cell Mol Biol, 32, pp.290~300 (2005)
28. Latella G, "Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice", Liver Int, 29, pp.997~1009 (2009)
29. Dooley S, "Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage", Gastroenterology, 135, pp.642~659 (2008)
30. Lo RC, "Histopathological evaluation of liver fibrosis and cirrhosis regression", Clin Mol Hepatol, 23, pp.302~307 (2017)
31. Murphy FR, "Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition : implications for reversibility of liver fibrosis", J Biol Chem, 277, pp.11069~11076 (2002)
32. Miyaki T, "Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats", Hepatol Res, 41, pp.375~385 (2011)
33. Xu L, "Human hepatic stellate cell lines, LX-1 and LX-2 : new tools for analysis of hepatic fibrosis", Gut, 54, pp.142~151 (2005)
34. Ohyama T, "Transforming growth factor-α attenuates hepatic fibrosis : possible involvement of matrix metalloproteinase-1", Liver Int, 31, pp.572~584 (2011)
35. Wataru Ando, "Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis", Clinical and Molecular Hepatology, 24(1), pp.61~76 (2018), 대한간학회
36. Kossakowska AE, "Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis", Am J Pathol, 153, pp.1895~1902 (1998)

관련 논문AI추천